Showing results (261-270 of 437) with videos related to
Sort By:
Pageof 44
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinibDavid M Jackman, Beow Y Yeap, Lecia V Sequist, et al.Blood|June 4, 2010
Recurrent BRAF mutations in Langerhans cell histiocytosisGayane Badalian-Very, Jo-Anne Vergilio, Barbara A Degar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2007
Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancerDavid M Jackman, Beow Y Yeap, Neal I Lindeman, et al.Angewandte Chemie (International Ed. in English)|November 22, 2013
Therapeutic targeting of oncogenic K-Ras by a covalent catalytic site inhibitorSang Min Lim, Kenneth D Westover, Scott B Ficarro, et al.Cancer Research|June 22, 2013
Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinomaRachel G Liao, Joonil Jung, Jeremy Tchaicha, et al.Cellular and Molecular Gastroenterology and Hepatology|February 9, 2017
Metagenomic Characterization of Microbial Communities In Situ Within the Deeper Layers of the Ileum in Crohn's DiseaseChandra Sekhar Pedamallu, Ami S Bhatt, Susan Bullman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Epidermal growth factor receptor mutation testing in the care of lung cancer patientsLecia V Sequist, Victoria A Joshi, Pasi A Jänne, et al.Nature Communications|May 13, 2020
Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancerJennifer Y Ge, Shaokun Shu, Mijung Kwon, et al.Cancer Cell|March 16, 2010
An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cellsQing Sheng, Xinggang Liu, Eleanor Fleming, et al.Genes & Development|January 17, 2013
Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional targetHideo Watanabe, Joshua M Francis, Michele S Woo, et al.Pageof 44